NCT07085975View on ClinicalTrials.gov

The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges

PHASE1RecruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 5, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

October 1, 2026

Conditions
Chronic Cough (CC)Asthma
Interventions
DRUG

Adenosine 5'-triphosphate

Participants will inhale increasing doubling concentrations of adenosine 5'-triphosphate dissolved in 0.9% saline through the Aerogen Solo vibrating mesh nebulizer.

Trial Locations (1)

L8N 3Z5

RECRUITING

Respiratory Research Lab, Hamilton

All Listed Sponsors
lead

McMaster University

OTHER